1. Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis

   • Francisco E. Vera-Badillo
   • Marc Napoleone
   • Eitan Amir

   Review 14 June 2014 Pages: 235 - 244

   

2. Pneumonitis and pulmonary fibrosis associated with breast cancer treatments

   • Claudia Omarini
   • Eirini Thanopoulou
   • Stephen R. D. Johnston

   Review 15 June 2014 Pages: 245 - 258

   

3. A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression

   • Jangsoon Lee
   • Chandra Bartholomeusz
   • Naoto T. Ueno

   Preclinical study 12 June 2014 Pages: 259 - 272

   

4. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth

   • Stefania Catalano
   • Cinzia Giordano
   • Ines Barone

   Preclinical study 14 June 2014 Pages: 273 - 285

   

5. Recurrent read-through fusion transcripts in breast cancer

   • Katherine E. Varley
   • Jason Gertz
   • Richard M. Myers

   Preclinical study Open access 15 June 2014 Pages: 287 - 297

   

6. Monitoring patient-centered outcomes through the progression of breast reconstruction: a multicentered prospective longitudinal evaluation

   • Li-Fen Chao
   • Ketan M. Patel
   • Ming-Huei Cheng

   Preclinical study 21 June 2014 Pages: 299 - 308

   

7. Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers

   • Tarek Abdel-Fatah
   • Arvind Arora
   • Srinivasan Madhusudan

   Preclinical study 28 June 2014 Pages: 309 - 320

   

8. Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

   • Kristi McIntyre
   • Joyce O’Shaughnessy
   • Linda T. Vahdat

   Clinical Trial Open access 04 April 2014 Pages: 321 - 328

   

9. Erratum to: Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

   • Kristi McIntyre
   • Joyce O’Shaughnessy
   • Linda T. Vahdat

   Erratum 19 June 2014 Pages: 329 - 329

10. Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting

    • Laura Evangelista
    • Anna Rita Cervino
    • Giorgio Saladini

    Clinical trial 18 June 2014 Pages: 331 - 340

    

11. Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04)

    • Jin Hee Kim
    • Doo Ho Choi
    • Chang-Ok Suh

    Clinical trial 18 June 2014 Pages: 341 - 345

    

12. Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast

    • C. Fraga-Guedes
    • H. Gobbi
    • G. Viale

    Clinical trial 19 June 2014 Pages: 347 - 354

    

13. Differential impact of body mass index on absolute and percent breast density: implications regarding their use as breast cancer risk biomarkers

    • Susann E. Schetter
    • Terryl J. Hartman
    • Andrea Manni

    Clinical trial 21 June 2014 Pages: 355 - 363

    

14. The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy

    • Amany R. Keruakous
    • Betro T. Sadek
    • Alphonse G. Taghian

    Clinical trial 22 June 2014 Pages: 365 - 370

    

15. Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?

    • Eva Maria Fallenberg
    • Clarisse Dromain
    • Florian Engelken

    Clinical trial 02 July 2014 Pages: 371 - 381

    

16. Dietary fat intake in relation to lethal breast cancer in two large prospective cohort studies

    • Caroline E. Boeke
    • A. Heather Eliassen
    • Rulla M. Tamimi

    Epidemiology 04 June 2014 Pages: 383 - 392

17. Pregnancy during breast cancer: does a mother’s parity status modify an offspring’s mortality risk?

    • Leonardo Simonella
    • Helena M. Verkooijen
    • Mikael Hartman

    Epidemiology 17 June 2014 Pages: 393 - 399

18. Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study

    • Jennifer H. Jordan
    • Soe Soe Thwin
    • Ann M. Geiger

    Epidemiology 18 June 2014 Pages: 401 - 409

    

19. Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival

    • Shi-Yi Wang
    • Jessica B. Long
    • Jersey Chen

    Epidemiology 21 June 2014 Pages: 411 - 419

    

20. Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

    • Jacek Gronwald
    • Andre Robidoux
    • The Hereditary Breast Cancer Clinical Study Group

    Epidemiology 21 June 2014 Pages: 421 - 427

21. Differential impact of non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus on breast reconstruction outcomes

    • Charles Qin
    • Elbert Vaca
    • John Y. S. Kim

    Epidemiology 25 June 2014 Pages: 429 - 438

    

22. Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women

    • Yong Cui
    • Sandra L. Deming-Halverson
    • Wei Zheng

    Epidemiology 02 July 2014 Pages: 439 - 446

23. Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer

    • K. Bell
    • N. Hodgson
    • K. Zbuk

    Brief Report 12 June 2014 Pages: 447 - 450

24. Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series

    • Vincent Sibaud
    • Rachel E. Niec
    • Mario E. Lacouture

    Brief Report 15 June 2014 Pages: 451 - 456

    

25. 3D volumetric analysis for planning breast reconstructive surgery

    • Michael P. Chae
    • David J. Hunter-Smith
    • Warren Matthew Rozen

    Brief Report 18 June 2014 Pages: 457 - 460